BostonGene Shines in 2025 Frost & Sullivan Global Innovation Leadership for AI-Driven Oncology Solutions BostonGene has earned Frost & Sullivan's recognition for 2025 Global Technology Innovation Leadership in AI-driven precision oncology solutions, celebrating impactful contributions in drug development.

BostonGene Shines in 2025 Frost & Sullivan Global Innovation Leadership for AI-Driven Oncology Solutions #USA #San_Antonio #BostonGene #Frost&Sullivan #PrecisionOncology

BostonGene Honored with Frost & Sullivan's Leadership Award for AI-Driven Precision Oncology Innovation BostonGene has been recognized with Frost & Sullivan's 2025 North American Enabling Technology Leadership Award for its innovative AI-driven oncology solutions that redefine precision medicine.

BostonGene Honored with Frost & Sullivan's Leadership Award for AI-Driven Precision Oncology Innovation #United_States #San_Antonio #AI_Innovation #Precision_Oncology #BostonGene